Immune repertoire: Revealing the "real-time" adaptive immune response in autoimmune diseases

被引:8
作者
Wu, Meiyu [1 ]
Zhao, Ming [1 ]
Wu, Haijing [1 ]
Lu, Qianjin [1 ,2 ]
机构
[1] Cent South Univ, Hunan Key Lab Med Epigen, Xiangya Hosp 2, Dept Dermatol, Changsha, Hunan, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Dermatol, Nanjing, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Immune repertoire; BCR; TCR; autoimmune diseases; SLE;
D O I
10.1080/08916934.2021.1887149
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The diversity of the immune repertoire (IR) enables the human immune system to distinguish multifarious antigens (Ags) that humans may encounter throughout life. At the same time, bias or abnormalities in the IR also pay a contribution to the pathogenesis of autoimmune diseases. Rapid advancements in high-throughput sequencing (HTS) technology have ushered in a new era of immune studies, revealing novel molecules and pathways that might result in autoimmunity. In the field of IR, HTS can monitor the immune response status and identify disease-specific immune repertoires. In this review, we summarize updated progress on the mechanisms of the IR and current related studies on four autoimmune diseases, particularly focusing on systemic lupus erythematosus (SLE). These autoimmune diseases can exhibit slightly or significantly skewed IRs and provide novel insights that inform our comprehending of disease pathogenesis and provide potential targets for diagnosis and treatment.
引用
收藏
页码:61 / 75
页数:15
相关论文
共 50 条
[41]   Mucosal-associated invariant T cells in autoimmune and immune-mediated diseases [J].
Rouxel, Ophelie ;
Lehuen, Agnes .
IMMUNOLOGY AND CELL BIOLOGY, 2018, 96 (06) :618-629
[42]   TREATMENT OF AUTOIMMUNE-DISEASES AND SYSTEMIC VASCULITIS WITH POOLED HUMAN INTRAVENOUS IMMUNE GLOBULIN [J].
JORDAN, SC ;
TOYODA, M .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 97 :31-38
[43]   Digital immunohistological dissection of immune privilege collapse in syringotropic autoimmune diseases: Implication for the pathogenesis [J].
Shimoda-Komatsu, Yurie ;
Yamazaki, Yoshimi ;
Tsukashima, Aki ;
Kimishima, Momoko ;
Ohyama, Manabu .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2021, 101 (01) :30-39
[44]   Heterogeneity of regulatory B cells in autoimmune diseases: implications for immune equilibrium and therapeutic strategies [J].
Yan, Haozhen ;
He, Jing ;
Lin, Xiang .
IMMUNOTHERAPY ADVANCES, 2025, 5 (01)
[45]   Genetically predicted metabolite mediates the causal relationship between immune cells and autoimmune diseases [J].
Wei, Jinpeng ;
Li, Jian ;
Li, Tianyang ;
Xu, Tao ;
Zhang, Yingchi ;
Yang, Shuhan ;
Wu, Hua ;
Hao, Haihu .
ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
[46]   The role of Nrf2 in immune cells and inflammatory autoimmune diseases: a comprehensive review [J].
Xu, Wang-Dong ;
Yang, Chan ;
Huang, An-Fang .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2024, 28 (09) :789-806
[47]   Genetic control of immune response in carriers of the 8.1 ancestral haplotype - Correlation with levels of IgG subclasses: Its relevance in the pathogenesis of autoimmune diseases [J].
Candore, Giuseppina ;
Campagna, Maria ;
Cuppari, Irene ;
Di Carlo, Daniele ;
Mineo, Claudia ;
Caruso, Calogero .
AUTOIMMUNITY, PT B: NOVEL APPLICATIONS OF BASIC RESEARCH, 2007, 1110 :151-158
[48]   Multidisciplinary approach to treatment with immune checkpoint inhibitors in patients with HIV, tuberculosis, or underlying autoimmune diseases [J].
Aguilar-Company, Juan ;
Lopez-Olivo, Maria A. ;
Ruiz-Camps, Isabel .
FRONTIERS IN MEDICINE, 2022, 9
[49]   Immune Monitoring to Predict the Development of Infections After Immunosuppression for Solid Organ Transplantation and Autoimmune Diseases [J].
Carbone, Javier ;
Lanio, Nallibe ;
Gallego, Antonio ;
Sarmiento, Elizabeth .
CURRENT DRUG SAFETY, 2008, 3 (02) :91-99
[50]   Microbiome research in autoimmune and immune- mediated inflammatory diseases: lessons, advances and unmet needs [J].
Scher, Jose U. ;
Nayak, Renuka ;
Clemente, Jose C. .
ANNALS OF THE RHEUMATIC DISEASES, 2025, 84 (01) :9-13